Rheumatoid Arthritis News

Hypertension is common in patients with early rheumatoid arthritis, and most frequently develops in older patients and those with traditional cardiovascular risk factors, according to data published in Rheumatology Advances in Practice.

SAN DIEGO — Vagus nerve stimulation may represent a “novel therapeutic option” for patients with rheumatoid arthritis, according to data presented at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — Obesity represents a significant barrier to treatment effectiveness, and by extension treatment satisfaction, in rheumatoid arthritis, according to data presented at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — Managing systemic inflammation is critical to reducing cardiovascular and pulmonary outcomes in patients with rheumatoid arthritis, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — Although a flood of COVID-19 and long COVID research continues to emerge, concerns may be limited for rheumatologists, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — Rheumatoid arthritis has received less attention than other diseases in recent years, but some “new concepts” may rouse it from its current “doldrums,” said a speaker at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — New imaging technologies, and improved use of the ones currently available, may move rheumatology closer to precision medicine in inflammatory arthritis, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

In this edition, blue-collar workers more likely to miss work or quit due to psoriatic arthritis, infliximab biosimilar increase after release of a third option and more.

Rates of osteoporosis and osteoporotic fractures have fallen significantly among patients with rheumatoid arthritis over the past 24 years, according to a single-center study published in RMD Open.

Switching from a TNF inhibitor to upadacitinib leads to significantly better outcomes in rheumatoid arthritis vs. cycling TNF inhibitors or switching to another mechanism of action, according to data published in Advances in Therapy.